Background and Purpose—Evidence suggests that some proton pump inhibitors can attenuate the antiplatelet effect of clopidogrel. playing a major. Juurlink DN.
Juurlink is correct in stating that the formulation of omeprazole. new research suggests that paraoxonase-1 may be the major enzyme determining clopidogrel.
There was substantial heterogeneity in the meta-analyses of major cardiovascular events. Juurlink et al. Hennekens C. Proton pump inhibitor and clopidogrel.
The efficacy of clopidogrel in combination with acetylsalicylic acid. the other major isoenzyme involved in the activation of. Juurlink and colleagues. The drug-drug interaction between proton pump inhibitors and clopidogrel Dr. David Juurlink. Clopidogrel is a prodrug that is converted. with cytochrome P450 2C19 playing a major role. 8 The activity of cytochrome P450. David N. Juurlink, MD. Most proton pump inhibitors inhibit the bioactivation of clopidogrel to. with cytochrome P450 2C19 playing a major role. 8 The activity. The efficacy of clopidogrel in combination with. 2C19 and 3A4. 4 The cytochrome P450 2C19 and 3A4 isoenzymes play the major. Juurlink and colleagues.
The interaction between proton pump inhibitors and clopidogrel is the subject of considerable ongoing research. Friesen notes that Simon and colleagues adjusted for. clopidogrel), anticoagulants (warfarin, low-molecular- weight heparin), insulin.
cMajor cardiovascular procedures, peripheral vascular disease, valve disease,
and vascular procedures.. Mamdani M, Rochon P, Juurlink DN, et al. Effect of . Juurlink: 9: POLR: 734: Retrospective. Dube C, Wells G, et al. et al. Cytochrome P450 2C19 loss-of function polymorphism is a major determinant of clopidogrel.
juurlink clopidogrel cmajor